In vivo use of all- trans retinoic acid prior to induction chemotherapy improves complete remission rate and increases rhodamine 123 uptake in patients with de novo acute myeloid leukemia

Verfasser / Beitragende:
[C. Üstün, M. Beksac, K. Dalva, H. Koc, N. Konuk, O. Ilhan, M. Özcan, P. Topcuoglu, D. Sertkaya, M. Hayran]
Ort, Verlag, Jahr:
2002
Enthalten in:
Medical Oncology, 19/1(2002-03-01), 59-67
Format:
Artikel (online)
ID: 471159697